Clemastine-induced Enhancement of Hippocampal Myelination Alleviates Memory Impairment in Mice with Chronic Pain

Ting-ting Zhu,He Wang,Pan-miao Liu,Han-wen Gu,Wei-tong Pan,Ming-ming Zhao,Kenji Hashimoto,Jian-jun Yang

DOI: https://doi.org/10.1016/j.nbd.2023.106375

IF: 7.046

2023-01-01

Neurobiology of Disease

Abstract:Patients with chronic pain often experience memory impairment, but the underlying mechanisms remain elusive. The myelin sheath is crucial for rapid and accurate action potential conduction, playing a pivotal role in the development of cognitive abilities in the central nervous system. The study reveals that myelin degradation occurs in the hippocampus of chronic constriction injury (CCI) mice, which display both chronic pain and memory impairment. Using fiber photometry, we observed diminished task-related neuronal activity in the hippocampus of CCI mice. Interestingly, the repeated administration with clemastine, which promotes myelination, counteracts the CCI-induced myelin loss and reduced neuronal activity. Notably, clemastine specifically ameliorates the impaired memory without affecting chronic pain in CCI mice. Overall, our findings highlight the significant role of myelin abnormalities in CCI-induced memory impairment, suggesting a potential therapeutic approach for treating memory impairments associated with neuropathic pain.